Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 35.12 | N/A |
| PEG Ratio (TTM) | 1.26 | N/A |
| P/S Ratio (TTM) | 0.98 | N/A |
| P/B Ratio (TTM) | 3.87 | N/A |
| P/FCF Ratio (TTM) | 13.27 | N/A |
| Price to 5YR AVG Earnings Ratio | -204.81 | N/A |
| Price to 5YR AVG FCF Ratio | 231.02 | N/A |
Profitability (23%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.54% | N/A |
| ROE (TTM) | 11.48% | N/A |
| Net Profit Margin (TTM) | 2.80% | N/A |
| ROIC 5YR AVG | 1.61% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 17.55% | -109.69% | 152.55% |
| Revenue | 8.61% | -2.76% | 1.54% |
| Net Income | 14.75% | -110.58% | 145.84% |
| Cash Flow | 3,262.75% | 26.02% | 92.39% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.56 | N/A |
| Quick Ratio (TTM) | 1.46 | N/A |
| D/E Ratio (TTM) | 0.73 | N/A |
| Interest Coverage (TTM) | 5.22 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.10 | N/A |
| LTL to 5YR AVG FCF | 40.23 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.20% | N/A |